JP2022533227A5 - - Google Patents
Info
- Publication number
- JP2022533227A5 JP2022533227A5 JP2021569059A JP2021569059A JP2022533227A5 JP 2022533227 A5 JP2022533227 A5 JP 2022533227A5 JP 2021569059 A JP2021569059 A JP 2021569059A JP 2021569059 A JP2021569059 A JP 2021569059A JP 2022533227 A5 JP2022533227 A5 JP 2022533227A5
- Authority
- JP
- Japan
- Prior art keywords
- angles
- ray powder
- powder diffraction
- diffraction peaks
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962851344P | 2019-05-22 | 2019-05-22 | |
| US62/851,344 | 2019-05-22 | ||
| PCT/US2020/033992 WO2020237047A1 (en) | 2019-05-22 | 2020-05-21 | Crystalline salt forms of n-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533227A JP2022533227A (ja) | 2022-07-21 |
| JP2022533227A5 true JP2022533227A5 (enExample) | 2023-05-29 |
Family
ID=71016713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569059A Ceased JP2022533227A (ja) | 2019-05-22 | 2020-05-21 | Ｎ－（４－（４－（シクロプロピルメチル）ピペラジン－１－カルボニル）フェニル）キノリン－８－スルホンアミドの結晶性塩形態 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230192618A1 (enExample) |
| EP (1) | EP3972957A1 (enExample) |
| JP (1) | JP2022533227A (enExample) |
| CN (2) | CN118206485A (enExample) |
| AU (1) | AU2020280045A1 (enExample) |
| CA (1) | CA3145138A1 (enExample) |
| IL (1) | IL288158A (enExample) |
| MX (2) | MX2021014228A (enExample) |
| WO (1) | WO2020237047A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240107326A (ko) | 2021-11-16 | 2024-07-09 | 아지오스 파마슈티컬스 아이엔씨. | Mds 관련 빈혈 및 기타 상태를 치료하기 위한 화합물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602007011792D1 (de) * | 2006-10-27 | 2011-02-17 | Fmc Corp | Gemeinsam aufbereitete mikrokristalline cellulose und zuckeralkohol als hilfsstoff für tablettenformulierungen |
| PE20120693A1 (es) * | 2009-06-29 | 2012-07-04 | Agios Pharmaceuticals Inc | Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2) |
| UY36680A (es) * | 2015-05-19 | 2016-12-30 | Glaxosmithkline Ip Dev Ltd | Amidas heterocíclicas como inhibidores de quinasa |
| MX384883B (es) | 2015-06-11 | 2025-03-14 | Agios Pharmaceuticals Inc | Métodos para usar activadores de piruvato cinasa. |
| KR102682430B1 (ko) * | 2017-11-22 | 2024-07-08 | 아지오스 파마슈티컬스 아이엔씨. | N-(4-(4-(시클로프로필메틸)피페라진-1-카르보닐)페닐)퀴놀린-8-술폰아미드의 결정 형태 |
-
2020
- 2020-05-21 JP JP2021569059A patent/JP2022533227A/ja not_active Ceased
- 2020-05-21 US US17/612,554 patent/US20230192618A1/en not_active Abandoned
- 2020-05-21 CN CN202410205860.2A patent/CN118206485A/zh active Pending
- 2020-05-21 AU AU2020280045A patent/AU2020280045A1/en not_active Abandoned
- 2020-05-21 EP EP20731357.8A patent/EP3972957A1/en not_active Withdrawn
- 2020-05-21 WO PCT/US2020/033992 patent/WO2020237047A1/en not_active Ceased
- 2020-05-21 CA CA3145138A patent/CA3145138A1/en active Pending
- 2020-05-21 CN CN202080045139.1A patent/CN114026071B/zh not_active Expired - Fee Related
- 2020-05-21 MX MX2021014228A patent/MX2021014228A/es unknown
-
2021
- 2021-11-16 IL IL288158A patent/IL288158A/en unknown
- 2021-11-19 MX MX2024009648A patent/MX2024009648A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021504338A5 (enExample) | ||
| JP7275130B2 (ja) | Ｎ－（４－（４－（シクロプロピルメチル）ピペラジン－１－カルボニル）フェニル）キノリン－８－スルホンアミドの結晶性形態 | |
| KR102425226B1 (ko) | Jak 저해제를 포함하는 제약 조성물 | |
| TWI846166B (zh) | {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式，其組合物及用途 | |
| TW200800221A (en) | δD-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | |
| JP7667270B2 (ja) | １－（３－シアノ－１－イソプロピル－インドール－５－イル）ピラゾール－４－カルボン酸の結晶性粒子の製造方法およびそれを含む薬学的組成物 | |
| CN115427112B (zh) | 2-[(4s)-8-氟-2-[4-(3-甲氧基苯基)哌嗪-1-基]-3-[2-甲氧基-5-(三氟甲基)苯基]-4h-喹唑啉-4-基]乙酸钾盐 | |
| US11345706B2 (en) | Crystalline forms of Acalabrutinib | |
| JP2023536667A5 (enExample) | ||
| US20170226119A1 (en) | Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof | |
| KR20130095735A (ko) | 테노포비어 디소프록실 푸마레이트의 결정 | |
| CN114026071B (zh) | N-(4-(4-(环丙基甲基)哌嗪-1-羰基)苯基)喹啉-8-磺酰胺的结晶盐形式 | |
| JP2022007461A (ja) | トルバプタン含有口腔内崩壊錠 | |
| NZ805778A (en) | Crystalline forms of n-(4-(4-(cyclopropylmethyl)piperazine-1- carbonyl)phenyl)quinoline-8-sulfonamide | |
| WO2018150335A1 (en) | Novel cocrystal of lesinurad and process for the preparation thereof | |
| US20200002343A1 (en) | Crystalline Form of Ribociclib Succinate | |
| EA049155B1 (ru) | Калиевая соль 2-[(4s)-8-фтор-2-[4-(3-метоксифенил)пиперазин-1-ил]-3-[2-метокси-5-(трифторметил)фенил]-4н-хиназолин-4-ил]уксусной кислоты | |
| HK1213549B (en) | Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof |